Delivery Order SPE2DB24D2101-SPE2DB25FKPBM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Twinrix vaccine in syringe form, with a contract value of $2,184.12 and an ultimate completion date of July 31, 2025. This non-set-aside contract utilizes firm fixed price pricing and is classified as a delivery order under the company's existing indefinite delivery contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,567.95 delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $149,035.14 for TWINRIX vaccine in syringe format on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment of pharmaceutical medical supply needs through the federal procurement process. The contract is performed at AmerisourceBergen's corporate office location...
- This delivery order awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $1,501.83 for the supply of Twinrix vaccine in syringe format. The contract was awarded on August 18, 2025, by the Defense Logistics Agency (DLA) with an ultimate completion date of August 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $129,484.53 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price contract was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract represents a non-set-aside procurement, indicating open competition among eligible vendors. Performance will take place at the awardee's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes valued at $2,679.52. This non-competitive, firm fixed-price delivery order was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line item procurement fulfilling federal medical supply requirements under the Defense Health...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $7,734.62 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Twinrix vaccine syringes. This non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $91,647.30 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price contract was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format, with a ceiling value of $1,747.78. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 29, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPBMDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Twinrix vaccine in syringe form, with a contract ceiling value of $1,815.66. The contract was awarded on a firm fixed-price basis with an ultimate completion date of September 3, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, competitively awarded action with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a prime IDC holder, AmerisourceBergen Drug Corp serves as a critical pharmaceutical vendor supporting military healthcare systems and the Defense Health Agency with a comprehensive portfolio of medications, vaccines, and medical supplies. The company's established role as a major pharmaceutical distributor positions it to fulfill federal medical procurement needs across multiple therapeutic domains, with this specific delivery order supporting vaccine distribution requirements for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/2/25 |